A recent genetic study with larger cohort identified eight de novo variants of NR4A2 and a deletion containing NR4A2 in nine patients with NDD and epilepsy, further strengthening the association of NR4A2 heterozygous variants with NDD (Singh et al., 2020). The gene discussed is NR4A2; the disease is epilepsy.